These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 34572066)

  • 21. Endocrine Fibroblast Growth Factors in Relation to Stress Signaling.
    Shimizu M; Sato R
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Klotho gene family as a regulator of endocrine fibroblast growth factors.
    Kurosu H; Kuro-O M
    Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGF19 subfamily members: FGF19 and FGF21.
    Dolegowska K; Marchelek-Mysliwiec M; Nowosiad-Magda M; Slawinski M; Dolegowska B
    J Physiol Biochem; 2019 Jun; 75(2):229-240. PubMed ID: 30927227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGF Family: From Drug Development to Clinical Application.
    Hui Q; Jin Z; Li X; Liu C; Wang X
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29949887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression.
    Feng S; Dakhova O; Creighton CJ; Ittmann M
    Cancer Res; 2013 Apr; 73(8):2551-62. PubMed ID: 23440425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor.
    Goetz R; Ohnishi M; Kir S; Kurosu H; Wang L; Pastor J; Ma J; Gai W; Kuro-o M; Razzaque MS; Mohammadi M
    J Biol Chem; 2012 Aug; 287(34):29134-46. PubMed ID: 22733815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities.
    Wu X; Li Y
    Adv Exp Med Biol; 2012; 728():195-213. PubMed ID: 22396171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circadian Regulation of Endocrine Fibroblast Growth Factors on Systemic Energy Metabolism.
    Yang Z; Zarbl H; Guo GL
    Mol Pharmacol; 2024 Feb; 105(3):179-193. PubMed ID: 38238100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.
    Goetz R; Beenken A; Ibrahimi OA; Kalinina J; Olsen SK; Eliseenkova AV; Xu C; Neubert TA; Zhang F; Linhardt RJ; Yu X; White KE; Inagaki T; Kliewer SA; Yamamoto M; Kurosu H; Ogawa Y; Kuro-o M; Lanske B; Razzaque MS; Mohammadi M
    Mol Cell Biol; 2007 May; 27(9):3417-28. PubMed ID: 17339340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease.
    Kondo Y; Komaba H; Fukagawa M
    Expert Rev Mol Diagn; 2020 Jul; 20(7):715-724. PubMed ID: 32513031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.
    Degirolamo C; Sabbà C; Moschetta A
    Nat Rev Drug Discov; 2016 Jan; 15(1):51-69. PubMed ID: 26567701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
    Dianat-Moghadam H; Teimoori-Toolabi L
    Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosylation of FGF/FGFR: An underrated sweet code regulating cellular signaling programs.
    Gędaj A; Gregorczyk P; Żukowska D; Chorążewska A; Ciura K; Kalka M; Porębska N; Opaliński Ł
    Cytokine Growth Factor Rev; 2024 Jun; 77():39-55. PubMed ID: 38719671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic dissection of sequence elements determining β-Klotho and FGF interaction and signaling.
    Shi SY; Lu YW; Richardson J; Min X; Weiszmann J; Richards WG; Wang Z; Zhang Z; Zhang J; Li Y
    Sci Rep; 2018 Jul; 8(1):11045. PubMed ID: 30038432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone.
    Wöhrle S; Bonny O; Beluch N; Gaulis S; Stamm C; Scheibler M; Müller M; Kinzel B; Thuery A; Brueggen J; Hynes NE; Sellers WR; Hofmann F; Graus-Porta D
    J Bone Miner Res; 2011 Oct; 26(10):2486-97. PubMed ID: 21812026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women.
    Ramanjaneya M; Bensila M; Bettahi I; Jerobin J; Samra TA; Aye MM; Alkasem M; Siveen KS; Sathyapalan T; Skarulis M; Atkin SL; Abou-Samra AB
    Front Endocrinol (Lausanne); 2020; 11():568500. PubMed ID: 33101202
    [No Abstract]   [Full Text] [Related]  

  • 37. Relevant use of Klotho in FGF19 subfamily signaling system in vivo.
    Tomiyama K; Maeda R; Urakawa I; Yamazaki Y; Tanaka T; Ito S; Nabeshima Y; Tomita T; Odori S; Hosoda K; Nakao K; Imura A; Nabeshima Y
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1666-71. PubMed ID: 20080590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis.
    Wu X; Li Y
    Aging (Albany NY); 2009 Dec; 1(12):1023-7. PubMed ID: 20157585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology.
    Belov AA; Mohammadi M
    Cold Spring Harb Perspect Biol; 2013 Jun; 5(6):. PubMed ID: 23732477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
    Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
    J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.